Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 7/20 | 0.41 |
| ▸ | PPARA | Q07869 | 6/20 | 0.41 |
| ▸ | HNF4A | P41235 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.37 |
| ▸ | S1PR1 | P21453 | 3/20 | 0.36 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.35 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.34 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.33 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12557289 | 0.92 | POLB (0.42) | PPARGPPARANPC1RAB9AHDAC8 | |
| SCHEMBL12557310 | 0.89 | NPC1 (0.40) | PPARGPPARANPC1RAB9AS1PR1 | |
| SCHEMBL12557272 | 0.89 | PPARG (0.37) | PPARGPPARAHNF4ANPC1RAB9A | |
| SCHEMBL12557349 | 0.87 | HDAC8 (0.50) | PPARGPPARANPC1RAB9AHDAC8 | |
| SCHEMBL12557276 | 0.86 | PPARG (0.42) | PPARGPPARANPC1RAB9AHDAC8 | |
| SCHEMBL12557306 | 0.85 | MAOB (0.42) | PPARGPPARARAB9AHDAC8S1PR1 | |
| SCHEMBL12557365 | 0.85 | PPARG (0.42) | PPARGPPARANPC1RAB9AHDAC8 | |
| SCHEMBL12557354 | 0.85 | HDAC8 (0.41) | PPARGPPARANPC1RAB9AHDAC8 | |
| SCHEMBL12557369 | 0.84 | HDAC8 (0.43) | PPARGPPARANPC1RAB9AHDAC8 | |
| SCHEMBL12557285 | 0.84 | S1PR1 (0.43) | PPARGPPARANPC1RAB9AHDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110144374-A1 | OXIME ETHER DERIVATIVE AND FUNGICIDE FOR AGRICULTURE AND HORTICULTURE | NIPPON SODA CO., LTD. (JP) | 2011-06-16 | — | — | US | disclosed |
| US-20110144374-A1 | OXIME ETHER DERIVATIVE AND FUNGICIDE FOR AGRICULTURE AND HORTICULTURE | NIPPON SODA CO., LTD. (JP) | 2011-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110144374-A1 | OXIME ETHER DERIVATIVE AND FUNGICIDE FOR AGRICULTURE AND HORTICULTURE | CBR3, CNPY2, NOX3 | PPARG 2729/4885PPARA 2732/4885HNF4A 2710/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.